Tom Cohen

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

—

by

Tom Cohen
in

GHR’s total investment in C2N has now broken $50 million since 2020.

Read More

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *